Completed PHASE1 INTERVENTIONAL 2-arm NCT02477956

Effect of a Monthly High Dose of Vitamin D3 on Bariatric Surgery Patients

Impact of Monthly High Dose Oral Cholecalciferol on Serum 25 Hydroxy Vitamin D Levels in Bariatric Surgery Subjects

Sponsor: Texas Tech University

Conditions Morbid Obesity Vitamin D Deficiency

Interventions vitamin D vitamin D3 (Replesta)

Updated 5 times since 2017 Last updated: Jun 22, 2015 Started: Nov 30, 2012 Primary completion: Nov 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Morbid Obesity and Vitamin D Deficiency, this trial is completed. The trial is conducted by Texas Tech University and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Texas Tech University

Data source: Texas Tech University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lubbock, United States